Trial Profile
Modification of ocular graft-versus-host disease development by early local Cyclosporin A application in patients after donor stem cell transplant.
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Dec 2010
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Povidone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms ocuGVHD CsA
- 09 Dec 2010 New trial record